Evaxion AS (EVAX)
3.36
+0.05
(+1.51%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
-0.15
(-4.46%)
After-Hours: 20:00
Evaxion Debt to Equity Ratio : 0.7455 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.7455 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.4404 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 1.812 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 8.371 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | -2.299 |
| September 30, 2023 | -3.770 |
| June 30, 2023 | 4.139 |
| March 31, 2023 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2022 | 1.235 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.39 |
| December 31, 2021 | 0.1138 |
| September 30, 2021 | 0.2321 |
| June 30, 2021 | 0.0508 |
| March 31, 2021 | 0.0399 |
| December 31, 2020 | 0.0028 |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.0038 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Autolus Therapeutics Plc | 4.915 |
| Cellectis SA | 2.539 |
| Akari Therapeutics Plc | 0.0373 |
| DBV Technologies SA | 0.0784 |
| argenx SE | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 19.38M |
| Total Liabilities (Quarterly) | 9.849M |
| Shareholders Equity (Quarterly) | 9.531M |
| Current Ratio | 5.062 |
| Net Debt Paydown Yield | -5.50% |